Bharat Biotech Initiates MTBVAC Tuberculosis Vaccine Clinical Trials In India
The Bharat Biotech clinical on Sunday Expressed trials for the novel tuberculosis (TB) vaccine MTBVAC in India mark a significant milestone in the global fight against one of the deadliest infectious diseases, claiming over 1.6 million lives annually worldwide. Developed through ...